Oncologic Results and Quality of Life in Patients with T3 Glottic Cancer After Transoral Laser Microsurgery

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2021 Jan 6

PMID 33403435

Citations 4

Authors

Pei-Ju Chien

Li-Ting Hung

Ling-Wei Wang

Muh-Hwa Yang

Pen-Yuan Chu

Affiliations

Soon will be listed here.

Abstract

Purpose: CO transoral laser microsurgery (CO2 TOLMS) is an alternative approach to non-surgical organ preservation in selected T3 glottic squamous cell carcinoma (SCC). This study aimed to assess the oncologic results and quality of life (QOL) of patients with T3 glottic SCC after CO2 TOLMS.

Methods: Of the 44 patients who underwent CO2 TOLMS, 38 underwent QOL evaluations. QOL was measured using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and head and neck module, Voice Handicap Index-30, and M. D. Anderson Dysphagia Inventory at least 6 months postoperatively.

Results: The patients were predominantly male (98%), with a median age of 61 years. Cordectomy type included 1 type III, 4 type IV, 31 type V, and 8 type VI according to European Laryngological Society classification. Two patients (5%) had cervical lymph node metastasis and 21 patients (48%) underwent postoperative radiotherapy. With a mean follow-up of 65 months for all patients, 10 (23%) had tumor recurrence (9 local, 1 distant). After salvage surgery, four patients lived without disease, and the larynx was preserved in two. The 5-year local control and overall and disease-specific survival rates were 78%, 75%, and 84%, respectively. The overall laryngeal preservation rate was 82% (36/44). Most patients had satisfactory QOL.

Conclusions: In selected T3 glottic SCC cases, CO2 TOLMS can achieve favorable oncologic results and a satisfactory QOL.

Citing Articles

Is CO laser microsurgery better than radiotherapy in early glottic cancer: a meta-analysis.

Yang Y, Wang Y, Wei L, Wang J, Huang F, Huang G Lasers Med Sci. 2023; 38(1):223.

PMID: 37758965 PMC: 10533611. DOI: 10.1007/s10103-023-03890-3.

CO laser combined with low-temperature plasma radiofrequency ablation promotes recovery of swallowing function in elderly patients with early glottic carcinoma.

Song Y, Liu X, Feng H Am J Transl Res. 2023; 15(8):5314-5322.

PMID: 37692942 PMC: 10492083.

[Study on the indication of concurrent chemoradiotherapy for locally advanced laryngeal carcinoma].

Wang W, Huangfu H, Hou Y, Feng Y, Zhang C, Zhai S Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022; 36(9):721-725.

PMID: 36036077 PMC: 10127619. DOI: 10.13201/j.issn.2096-7993.2022.09.015.

Retrospective analysis of risk factors for lymph node metastasis in recurrent glottic cancer after primary laser surgery: a cohort study from China.

Chen X, Huang J, Ding S, Yin G, Gao W, Zhang Y Ann Transl Med. 2022; 10(14):799.

PMID: 35965819 PMC: 9372678. DOI: 10.21037/atm-22-3385.

References

Hoffman H, Porter K, Karnell L, Cooper J, Weber R, Langer C . Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006; 116(9 Pt 2 Suppl 111):1-13. DOI: 10.1097/01.mlg.0000236095.97947.26. View

Chen A, Fedewa S, Zhu J . Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007. Arch Otolaryngol Head Neck Surg. 2011; 137(10):1017-24. DOI: 10.1001/archoto.2011.171. View

Forastiere A, Goepfert H, Maor M, Pajak T, Weber R, Morrison W . Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003; 349(22):2091-8. DOI: 10.1056/NEJMoa031317. View

Machtay M, Moughan J, Trotti A, Garden A, Weber R, Cooper J . Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008; 26(21):3582-9. PMC: 4911537. DOI: 10.1200/JCO.2007.14.8841. View

Genden E, Ferlito A, Silver C, Jacobson A, Werner J, Suarez C . Evolution of the management of laryngeal cancer. Oral Oncol. 2006; 43(5):431-9. DOI: 10.1016/j.oraloncology.2006.08.007. View

Remacle M, Van Haverbeke C, Eckel H, Bradley P, Chevalier D, Djukic V . Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol. 2007; 264(5):499-504. DOI: 10.1007/s00405-007-0279-z. View

Chu P, Hsu Y, Lee T, Fu S, Wang L, Kao Y . Modified type III cordectomy to improve voice outcomes after transoral laser microsurgery for early glottic canser. Head Neck. 2011; 34(10):1422-7. DOI: 10.1002/hed.21936. View

Forastiere A, Zhang Q, Weber R, Maor M, Goepfert H, Pajak T . Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2012; 31(7):845-52. PMC: 3577950. DOI: 10.1200/JCO.2012.43.6097. View

Mercante G, Grammatica A, Battaglia P, Cristalli G, Pellini R, Spriano G . Supracricoid partial laryngectomy in the management of t3 laryngeal cancer. Otolaryngol Head Neck Surg. 2013; 149(5):714-20. DOI: 10.1177/0194599813500018. View

10.

Nakayama M, Miyamoto S, Seino Y, Okamoto T, Kano K, Hasebe M . One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control?. Jpn J Clin Oncol. 2015; 45(8):732-7. DOI: 10.1093/jjco/hyv072. View

11.

Gong H, Zhou L, Wu H, Tao L, Chen X, Li X . Long-term clinical outcomes of supracricoid partial laryngectomy with cricohyoidoepiglottopexy for glottic carcinoma. Acta Otolaryngol. 2019; 139(9):803-809. DOI: 10.1080/00016489.2019.1616820. View

12.

Laccourreye H, Laccourreye O, Weinstein G, Menard M, Brasnu D . Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas. Laryngoscope. 1990; 100(7):735-41. DOI: 10.1288/00005537-199007000-00009. View

13.

Lee S, Shores C, Weissler M . Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg. 2008; 16(2):135-40. DOI: 10.1097/MOO.0b013e3282f495b6. View

14.

STRONG M, Jako G . Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser. Ann Otol Rhinol Laryngol. 1972; 81(6):791-8. DOI: 10.1177/000348947208100606. View

15.

Silver C, Beitler J, Shaha A, Rinaldo A, Ferlito A . Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol. 2009; 266(9):1333-52. DOI: 10.1007/s00405-009-1028-2. View

16.

Mo H, Li J, Yang X, Zhang F, Xiong J, Yang Z . Transoral laser microsurgery versus radiotherapy for T1 glottic carcinoma: a systematic review and meta-analysis. Lasers Med Sci. 2016; 32(2):461-467. DOI: 10.1007/s10103-016-2103-8. View

17.

Canis M, Ihler F, Martin A, Wolff H, Matthias C, Steiner W . Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery. Head Neck. 2013; 36(5):652-9. DOI: 10.1002/hed.23338. View

18.

Vilaseca I, Bernal-Sprekelsen M, Blanch J . Transoral laser microsurgery for T3 laryngeal tumors: Prognostic factors. Head Neck. 2009; 32(7):929-38. DOI: 10.1002/hed.21288. View

19.

Hinni M, Salassa J, Grant D, Pearson B, Hayden R, Martin A . Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2007; 133(12):1198-204. DOI: 10.1001/archotol.133.12.1198. View

20.

Motta G, Esposito E, Motta S, Tartaro G, Testa D . CO(2) laser surgery in the treatment of glottic cancer. Head Neck. 2005; 27(7):566-73. DOI: 10.1002/hed.20135. View